Today, there are several important reports scheduled for release that could impact the market. While our robots have typically leaned towards market neutrality, they have recently started taking short positions. If I had to choose a robot for this week, I would select the Swing Trader Popular Stocks 4K per position Market Neutral Strategy, which tends to maintain market-neutral positions and has a track record of generating profits in any market condition.
ASML Holding N.V. (ASML)is reporting for the quarter ending March 31, 2023. The capital goods company's consensus earnings per share forecast from the 1 analyst that follows the stock is $4.59. This value represents a 27.86% increase compared to the same quarter last year. In the past year ASML and beat the expectations the other three quarters.
Abbott Laboratories (ABT)is reporting for the quarter ending March 31, 2023. The medical products company's consensus earnings per share forecast from the 9 analysts that follow the stock is $0.98. This value represents a 43.35% decrease compared to the same quarter last year. In the past year ABT has beat the expectations every quarter. The highest one was in the 4th calendar quarter where they beat the consensus by 14.44%.
Morgan Stanley (MS)is reporting for the quarter ending March 31, 2023. The investment bankers company's consensus earnings per share forecast from the 7 analysts that follow the stock is $1.67. This value represents a 18.93% decrease compared to the same quarter last year. MS missed the consensus earnings per share in the 2nd calendar quarter of 2022 by -7.1%.
Elevance Health, Inc. (ELV)is reporting for the quarter ending March 31, 2023. The medical services company's consensus earnings per share forecast from the 16 analysts that follow the stock is $9.30. This value represents a 12.73% increase compared to the same quarter last year. In the past year ELV has beat the expectations every quarter. The highest one was in the 4th calendar quarter where they beat the consensus by 0.58%.
U.S. Bancorp (USB)is reporting for the quarter ending March 31, 2023. The bank company's consensus earnings per share forecast from the 10 analysts that follow the stock is $1.13. This value represents a 14.14% increase compared to the same quarter last year. In the past year USB has beat the expectations every quarter. The highest one was in the 4th calendar quarter where they beat the consensus by 8.11%.
Nasdaq, Inc. (NDAQ) is set to report its earnings for the quarter ending March 31, 2023. The securities exchange company's consensus earnings per share forecast from the 9 analysts that follow the stock is $0.65, which is a 1.52% decrease compared to the same quarter last year. NDAQ missed the consensus earnings per share in the 4th calendar quarter of 2022 by -1.54%.
Citizens Financial Group, Inc. (CFG) is also reporting for the quarter ending March 31, 2023. The savings & loan company's consensus earnings per share forecast from the 8 analysts that follow the stock is $1.11, indicating a 3.74% increase compared to the same quarter last year. CFG missed the consensus earnings per share in the 4th calendar quarter of 2022 by -3.85%.
Synchrony Financial (SYF) is also set to report its earnings for the quarter ending March 31, 2023. The financial services company's consensus earnings per share forecast from the 13 analysts that follow the stock is $1.49, which represents a 13.87% decrease compared to the same quarter last year. However, in the past year, SYF has managed to beat expectations every quarter, with the highest beat being in the 4th calendar quarter, where they surpassed the consensus by 12.5%.
Ally Financial Inc. (ALLY) is reporting for the quarter ending March 31, 2023. The financial services company's consensus earnings per share forecast from the 8 analysts that follow the stock is $0.88, indicating a 56.65% decrease compared to the same quarter last year.
Lastly, Lithia Motors, Inc. (LAD) is reporting for the quarter ending March 31, 2023. The retail company's consensus earnings per share forecast from the 6 analysts that follow the stock is $8.77, which represents a 26.67% decrease compared to the same quarter last year.
The 10-day moving average for MS crossed bullishly above the 50-day moving average on May 06, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where MS's RSI Oscillator exited the oversold zone, of 19 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on April 17, 2025. You may want to consider a long position or call options on MS as a result. In of 68 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for MS just turned positive on April 15, 2025. Looking at past instances where MS's MACD turned positive, the stock continued to rise in of 40 cases over the following month. The odds of a continued upward trend are .
MS moved above its 50-day moving average on May 01, 2025 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MS advanced for three days, in of 345 cases, the price rose further within the following month. The odds of a continued upward trend are .
MS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In of 319 cases where MS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 11 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The 50-day moving average for MS moved below the 200-day moving average on May 05, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 68, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.694) is normal, around the industry mean (5.650). P/E Ratio (18.056) is within average values for comparable stocks, (34.620). Projected Growth (PEG Ratio) (3.334) is also within normal values, averaging (2.610). Dividend Yield (0.036) settles around the average of (0.031) among similar stocks. P/S Ratio (3.039) is also within normal values, averaging (80.764).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of diversified financial services including brokerage, investment management and venture capital services
Industry InvestmentBanksBrokers